Meta-analyses of Results From Randomized Outcome Trials Comparing Cardiovascular Effects of SGLT2is and GLP-1RAs in Asian Versus White Patients With and Without Type 2 Diabetes.

Matthew M Y LeeNazim GhouriDarren K McGuireMartin K RutterNaveed Sattar

Published in: Diabetes care (2021)

Compared with Whites, Asians may derive greater CV death/HHF benefit from SGLT2is in patients with HFrEF, and MACE benefit from GLP-1RAs in patients with type 2 diabetes.

Keyphrases

meta analyses
type diabetes
wild type
systematic review
double blind
open label
randomized controlled trial
placebo controlled
phase iii
glycemic control
cardiovascular disease
insulin resistance
clinical trial
adipose tissue
weight loss